| |
MR imaging |
FCH PET/CT |
AC PETCT |
|
| Pat. |
MRI |
MRS |
DCE MR |
DWI MR |
MR global |
1st dyn |
2nd dyn |
3rd dyn |
dyn global |
WB |
Late run |
FCH global |
1st WB |
2nd WB |
Late run |
AC global |
| 1 |
- |
+ |
+ |
+ |
+ |
|
|
|
|
|
|
|
± |
- |
- |
- |
|
| 2 |
- |
± |
± |
± |
± |
|
|
|
|
|
|
|
± |
± |
- |
- |
|
| 3 |
- |
- |
- |
± |
- |
|
|
|
|
|
|
|
- |
- |
- |
- |
|
| 4 |
- |
- |
± |
- |
- |
|
|
|
|
|
|
|
+ |
- |
- |
- |
|
| 5 |
- |
± |
± |
- |
± |
|
|
|
|
|
|
|
± |
± |
± |
- |
|
| 6 |
- |
± |
- |
- |
- |
|
|
|
|
|
|
|
+ |
± |
- |
- |
|
| 7 |
+ |
± |
± |
+ |
± |
|
|
|
|
|
|
|
- |
- |
- |
- |
|
| 8 |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
± |
± |
- |
- |
|
| 9 |
- |
± |
± |
- |
± |
|
|
|
|
|
|
|
± |
- |
- |
- |
|
| 10 |
- |
± |
- |
- |
- |
|
|
|
|
|
|
|
+ |
- |
- |
- |
|
| 11 |
- |
+ |
+ |
+ |
+ |
- |
- |
- |
± |
± |
- |
- |
|
|
|
|
|
| 12 |
- |
± |
- |
± |
± |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
| 13 |
- |
± |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
| 14 |
- |
- |
- |
- |
- |
± |
- |
- |
± |
- |
- |
- |
|
|
|
|
|
| 15 |
- |
± |
- |
- |
- |
± |
± |
± |
± |
± |
- |
- |
|
|
|
|
|
| 16 |
± |
± |
- |
- |
± |
± |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
| 17 |
- |
± |
- |
- |
- |
± |
+ |
+ |
+ |
+ |
± |
± |
|
|
|
|
|
| 18 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
| 19 |
- |
± |
- |
- |
- |
- |
± |
± |
± |
± |
- |
- |
|
|
|
|
|
| 20 |
- |
± |
- |
- |
- |
+ |
± |
± |
± |
± |
- |
- |
|
|
|
|
|
Abbreviations:
“+” = positive
“±” = equivocal
“-“ = negative
MRI = contrast enhanced T2-weighted magnet resonance imaging
MRS = Magnet resonance spectroscopy
DCE = dynamic contrast enhanced
DWI = diffusion-weighted imaging
FCH = 18F-Fluorocholine
dyn = dynamic PET scan
AC = 11C-acetate
WB = whole-body PET scan
A combined evaluation of prostate and seminal vesicle were performed in all patients |
